Literature DB >> 4596483

Assessment of coagulation and fibrinolysis in pre-eclampsia.

S M Wood, D Burnett, A M Picken, G W Farrell, P Wolf.   

Abstract

A method is described for distinguishing coagulation from fibrinolysis by three estimates of fibrinogen. This "fibrinogen series" together with plasma antithrombin and urinary urokinase have been compared in pregnant patients with venous thrombosis and pre-eclampsia. Evidence is presented for active coagulation during deterioration of the pre-eclampsia state and for enhanced fibrinolysis during improvement.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4596483      PMCID: PMC1610344          DOI: 10.1136/bmj.2.5911.145

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Hemostatic defects and increased red cell destruction in pre-eclampsia and eclampsia.

Authors:  J A PRITCHARD; O D RATNOFF; R WEISMAN
Journal:  Obstet Gynecol       Date:  1954-08       Impact factor: 7.661

Review 2.  On the pathogenesis of pre-eclampsia and eclampsia.

Authors:  E W Page
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-10

3.  Immunoephelometric determination of fibrinogen and its derivatives in plasma.

Authors:  G W Farrell; P Wolf
Journal:  J Immunol Methods       Date:  1972-05       Impact factor: 2.303

4.  A batch method for estimating thrombin clottable fibrinogen.

Authors:  G W Farrell; P Wolf
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

5.  Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency.

Authors:  P W Howie; C R Prentice; G P McNicol
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-11

6.  The measurement of fibrinogen and its derivatives. 3. Thrombin clottable fibrinogen estimates in the presence of epsilon amino caproic acid, fibrinogen and fibrin degradation products.

Authors:  G W Farrell; P Wolf
Journal:  Med Lab Technol       Date:  1971-07

7.  Fibrin degradation products in normal and abnormal pregnancy and parturition.

Authors:  J Bonnar; J F Davidson; C F Pidgeon; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1969-07-19

8.  The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis.

Authors:  P Wolf; G W Farrell; K W Walton
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

9.  Fibrin degradation products in pre-eclamptic toxaemia and eclampsia.

Authors:  A H Henderson; D J Pugsley; D P Thomas
Journal:  Br Med J       Date:  1970-09-05

10.  Significance of cryoprofibrin in fibrinogen-fibrin conversion.

Authors:  J R SHAINOFF; I H PAGE
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

View more
  1 in total

1.  Nephrotic syndrome, sickle-cell disease and pregnancy.

Authors:  A M Smith
Journal:  Postgrad Med J       Date:  1976-10       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.